Exact Mass: 330.0497

Exact Mass Matches: 330.0497

Found 55 metabolites which its exact mass value is equals to given mass value 330.0497, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Aluminium acetoacetate

Aluminium acetoacetate

C12H15AlO9 (330.0531)


A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02A - Antacids > A02AB - Aluminium compounds

   

6-(4-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(4-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


6-(4-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 3,4-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 3,4-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(4-carboxy-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(4-carboxy-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


6-(4-carboxy-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,4-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(2-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(2-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


6-(2-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,4-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(3-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(3-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


6-(3-carboxy-5-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 3,5-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(3-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(3-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


6-(3-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,3-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(2-carboxy-6-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(2-carboxy-6-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


6-(2-carboxy-6-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,3-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(3-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(3-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


6-(3-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,5-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

6-(2-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(2-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


6-(2-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2,5-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

Pirazolac

2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl]acetic acid

C17H12ClFN2O2 (330.0571)


   

Monosyringoyltartaric acid

Monosyringoyltartaric acid

C13H14O10 (330.0587)


   
   
   
   
   

3-allyl-5-(4-methoxyphenyl)-2-sulfanylthieno[2,3-d]pyrimidin-4(3h)-one

3-allyl-5-(4-methoxyphenyl)-2-sulfanylthieno[2,3-d]pyrimidin-4(3h)-one

C16H14N2O2S2 (330.0497)


   

2-(2,4-DINITROBENZYLTHIO)-1H-BENZO[D]IMIDAZOLE

2-(2,4-DINITROBENZYLTHIO)-1H-BENZO[D]IMIDAZOLE

C14H10N4O4S (330.0423)


   

4-[(2-chloro-5-(trifluoromethyl)phenoxy)methyl]phenylboronic acid

4-[(2-chloro-5-(trifluoromethyl)phenoxy)methyl]phenylboronic acid

C14H11BClF3O3 (330.0442)


   

3-((2-Chloro-5-(trifluoromethyl)phenoxy)methyl)phenylboronic acid

3-((2-Chloro-5-(trifluoromethyl)phenoxy)methyl)phenylboronic acid

C14H11BClF3O3 (330.0442)


   

N-[1-(2-HYDROXY-2-PHENYL-ETHYL)-PIPERIDIN-4-YL]-N-PHENYL-PROPIONAMIDE

N-[1-(2-HYDROXY-2-PHENYL-ETHYL)-PIPERIDIN-4-YL]-N-PHENYL-PROPIONAMIDE

C11H14ClF3N2O2S (330.0417)


   

1-(3-Chlorobenzyl)-1,2,3,4-tetrahydroquinoxaline

1-(3-Chlorobenzyl)-1,2,3,4-tetrahydroquinoxaline

C15H17Cl3N2 (330.0457)


   

4-[(4-chlorophenyl)methyl]-2,3-dihydro-1H-quinoxaline

4-[(4-chlorophenyl)methyl]-2,3-dihydro-1H-quinoxaline

C15H17Cl3N2 (330.0457)


   

sodium,[4-[2-(4-hydroxyphenyl)propan-2-yl]phenyl] sulfate

sodium,[4-[2-(4-hydroxyphenyl)propan-2-yl]phenyl] sulfate

C15H15NaO5S (330.0538)


   

1-(3,4-DIMETHYLPHENYL)-3-METHYL-3-PYRAZOLIN-5-ONE

1-(3,4-DIMETHYLPHENYL)-3-METHYL-3-PYRAZOLIN-5-ONE

C15H8F6N2 (330.0592)


   

ETHYL 6,6-DIMETHYL-3-(METHYLSULFONYL)-4-OXO-4,5,6,7-TETRAHYDROBENZO[C]THIOPHENE-1-CARBOXYLATE

ETHYL 6,6-DIMETHYL-3-(METHYLSULFONYL)-4-OXO-4,5,6,7-TETRAHYDROBENZO[C]THIOPHENE-1-CARBOXYLATE

C14H18O5S2 (330.0596)


   

4-[(2-chlorophenyl)methyl]-2,3-dihydro-1H-quinoxaline

4-[(2-chlorophenyl)methyl]-2,3-dihydro-1H-quinoxaline

C15H17Cl3N2 (330.0457)


   

2-(4-Bromo-2-fluoro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-Bromo-2-fluoro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C13H17BBrFO3 (330.0438)


   

Pirazolac

Pirazolac

C17H12ClFN2O2 (330.0571)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

6-Chloro-5-(2-methoxyphenoxy)-2,2-bipyrimidin-4(5H)-one

6-Chloro-5-(2-methoxyphenoxy)-2,2-bipyrimidin-4(5H)-one

C15H11ClN4O3 (330.052)


   

2-(6-BROMO-2-FLUORO-3-METHOXYPHENYL)-1,3,2-DIOXABOROLANE

2-(6-BROMO-2-FLUORO-3-METHOXYPHENYL)-1,3,2-DIOXABOROLANE

C13H17BBrFO3 (330.0438)


   

(2-((2-Chloro-5-(trifluoromethyl)phenoxy)methyl)phenyl)boronic acid

(2-((2-Chloro-5-(trifluoromethyl)phenoxy)methyl)phenyl)boronic acid

C14H11BClF3O3 (330.0442)


   

3-(1H-TETRAZOL-5-YL)-9H-THIOXANTHEN-9-O&

3-(1H-TETRAZOL-5-YL)-9H-THIOXANTHEN-9-O&

C14H10N4O4S (330.0423)


   

6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one

6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one

C17H12ClFN2O2 (330.0571)


   

Geranyl S-thiolodiphosphate

Geranyl S-thiolodiphosphate

C10H20O6P2S (330.0456)


   

6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


6-(5-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 3,4-dihydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

4-[(4-chlorobenzyl)amino]-3-nitro-2H-chromen-2-one

4-[(4-chlorobenzyl)amino]-3-nitro-2H-chromen-2-one

C16H11ClN2O4 (330.0407)


   

(5E)-1-[(4-fluorophenyl)methyl]-5-(thiophen-2-ylmethylidene)-1,3-diazinane-2,4,6-trione

(5E)-1-[(4-fluorophenyl)methyl]-5-(thiophen-2-ylmethylidene)-1,3-diazinane-2,4,6-trione

C16H11FN2O3S (330.0474)


   

N-[4-(6-chloro-5-nitro-1H-benzimidazol-2-yl)phenyl]acetamide

N-[4-(6-chloro-5-nitro-1H-benzimidazol-2-yl)phenyl]acetamide

C15H11ClN4O3 (330.052)


   

2-(4-fluorophenoxy)-N-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)acetamide

2-(4-fluorophenoxy)-N-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)acetamide

C15H11FN4O2S (330.0587)


   

3-(2-fluorophenyl)-4-oxo-2-sulfanylidene-1H-quinazoline-7-carboxylic acid methyl ester

3-(2-fluorophenyl)-4-oxo-2-sulfanylidene-1H-quinazoline-7-carboxylic acid methyl ester

C16H11FN2O3S (330.0474)


   

N-[3-(1,3-benzothiazol-2-yl)-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl]acetamide

N-[3-(1,3-benzothiazol-2-yl)-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl]acetamide

C16H14N2O2S2 (330.0497)


   
   

5-[(4,7-dihydroxy-2-oxochromen-3-yl)carbamoyl]-1H-pyrrole-2-carboxylic acid

5-[(4,7-dihydroxy-2-oxochromen-3-yl)carbamoyl]-1H-pyrrole-2-carboxylic acid

C15H10N2O7 (330.0488)


   

6-(2-Formyl-3,5-dihydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(2-Formyl-3,5-dihydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


   

3,4-Dihydroxybenzoic acid 3-O-beta-D-glucuronide

3,4-Dihydroxybenzoic acid 3-O-beta-D-glucuronide

C13H14O10 (330.0587)


   

6-(4-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(4-carboxy-2-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


   

6-(4-carboxy-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(4-carboxy-3-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


   

6-(3-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(3-carboxy-4-hydroxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O10 (330.0587)


   

cacibiocin A

cacibiocin A

C15H10N2O7 (330.0488)


An aminocoumarin resulting from the formal condensation of one of the carboxy groups of pyrrole-2,5-dicarboxylic acid with the amino group of 3-amino-4,7-dihydroxycoumarin. It is a natural product isolated from Catenulispora acidiphila that doesnt exhibit an antimicrobial activity contrary to most aminocoumarins.

   

2-chloro-4-[5-(penta-1,3-diyn-1-yl)thiophen-2-yl]but-3-yn-1-yl 2-methylbut-2-enoate

2-chloro-4-[5-(penta-1,3-diyn-1-yl)thiophen-2-yl]but-3-yn-1-yl 2-methylbut-2-enoate

C18H15ClO2S (330.0481)


   

4-({7-bromo-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-3h-imidazole

4-({7-bromo-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-3h-imidazole

C15H15BrN4 (330.048)


   

4,7,9-trihydroxybenzo[j]fluoranthene-3,8-dione

4,7,9-trihydroxybenzo[j]fluoranthene-3,8-dione

C20H10O5 (330.0528)


   

(2s)-2-chloro-4-[5-(penta-1,3-diyn-1-yl)thiophen-2-yl]but-3-yn-1-yl (2z)-2-methylbut-2-enoate

(2s)-2-chloro-4-[5-(penta-1,3-diyn-1-yl)thiophen-2-yl]but-3-yn-1-yl (2z)-2-methylbut-2-enoate

C18H15ClO2S (330.0481)